Bromazolam and clonazolam detected in ‘Mylan’ pill4 Mar 2026ACTBenzodiazepines DepressantsA white ‘Mylan’ pill expected to contain a benzodiazepine was found to contain bromazolam and clonazolam. This sample was acquired in Sydney but was tested by Pill Testing Australia at DIGI Festival (Canberra). WHAT DOES THIS MEAN? Clonazolam is a novel benzodiazepine, or ‘Benzo’. Benzos are typically used to sedate and treat anxiety. Clonazolam has a strong sedative effect, knownRead notification
Carisoprodol (Soma®) sold as diazepam19 Feb 2026VICBenzodiazepines DepressantsWhat is Carisoprodol (Soma®)? Carisoprodol is a muscle relaxant medication used to treat painful musculoskeletal conditions. It was marketed under the trade name Soma®. It is no longer commonly prescribed in Australia. Carisoprodol acts similarly to diazepam (Valium®) however it is metabolised into meprobamate, which acts more like a barbiturate by directly binding to GABAA receptors. Generally, carisoprodol is consideredRead notification
AB-MDMSBA (a synthetic cannabinoid) found in alprazolam (Xanax®)12 Feb 2026VICBenzodiazepines CannabinoidsA white tablet expected to contain Alprazolam was found to contain a synthetic cannabinoid –AB-MDMSBA. What is AB- MDMSBA? AB-MDMSBA is a novel synthetic cannabinoid and is structurally similar to other known synthetic cannabinoids. Synthetic cannabinoids are not the same as natural cannabis. We know very little about its specific effects and it has no references in clinical literature orRead notification
Medetomidine found in crystal / powder expected to contain bromazolam27 Nov 2025VICDepressants MedetomodineWhat is it? Medetomidine is a non-opioid sedative used as a veterinary drug.It is very potent — consuming even a small amount can result in heavy sedation. The sample was acquired in Victoria in the last week. Important to note: Medetomidine is NOT an opioid — its effects will not be reversed by naloxone. If purchasing bromazolam avoid use withRead notification
Rilmalzafone found in ‘opioid’ capsule18 Oct 2025ACTBenzodiazepines DepressantsA capsule filled with off-white powder expected to contain an unknown opioid was found to contain Rilmazafone. Rilmazafone is a benzodiazepine prodrug, meaning the body converts the substance into a benzo after consumption (rilmazolam). Because of the conversion time in the body, the onset of effects can be delayed and may take 2-3 hours or more. Rilmazafone is not readilyRead notification
Methylmethaqualone and flurofentanyl found in ‘opioid’ capsule3 Oct 2025ACTDepressants Fentanyl OpioidsA capsule filled with an off-white powder expected to contain an unknown opioid was found to contain methylmethqualone and a fluorofentanyl. CanTEST has detected MMQ by itself previously (a Yellow Community Notice was issued in Nov 2024). Effects Methylmethqualone (MMQ) is an analogue of the more common methaqualone (MQ). It’s a quinazolone sedative hypnotic – which is a central nervousRead notification